 | Up a level |
Tamari, Roni; McLornan, Donal P; Ahn, Kwang Woo; Estrada-Merly, Noel; Hernandez-Boluda, Juan Carlos; Giralt, Sergio A; Palmer, Jeanne M; Gale, Robert Peter; DeFilipp, Zachariah; Marks, David; van der Poel, Marjolein W M; Verdonck, Leo F; Battiwalla, Minoo; Díaz, Miguel A; Gupta, Vikas; Ali, Haris; Litzow, Mark R; Lazarus, Hillard M; Gergis, Usama; Bashey, Asad; ... (2023). A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis. Blood advances, 7(15), pp. 3993-4002. American Society of Hematology 10.1182/bloodadvances.2023009886
Mei, Matthew; Pillai, Raju; Kim, Soyoung; Estrada-Merly, Noel; Afkhami, Michelle; Yang, Lixin; Meng, Zhuo; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Beitinjaneh, Amer; Bredeson, Christopher; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; Cutler, Corey; DeFilipp, Zachariah; Diaz Perez, Miguel Angel; Farhadfar, Nosha; Freytes, César O; ... (2023). The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis. Haematologica - the hematology journal, 108(1), pp. 150-160. Ferrata-Storti Foundation 10.3324/haematol.2021.280203
Guru Murthy, Guru Subramanian; Kim, Soyoung; Hu, Zhen-Huan; Estrada-Merly, Noel; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Badawy, Sherif M; Beitinjaneh, Amer; Bredeson, Chris; Cahn, Jean-Yves; Cerny, Jan; Diaz Perez, Miguel Angel; Farhadfar, Nosha; Gale, Robert Peter; Ganguly, Siddhartha; Gergis, Usama; Hildebrandt, Gerhard C; Grunwald, Michael R; Hashmi, Shahrukh; ... (2022). Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors. JAMA oncology, 8(3), pp. 404-411. American Medical Association 10.1001/jamaoncol.2021.6846
Wieduwilt, Matthew J; Metheny, Leland; Zhang, Mei-Jie; Wang, Hai-Lin; Estrada-Merly, Noel; Marks, David I; Al-Homsi, A Samar; Muffly, Lori; Chao, Nelson J; Rizzieri, David; Gale, Robert Peter; Gadalla, Shahinaz M; Cairo, Mitchell S; Mussetti, Alberto; Gore, Steven D; Bhatt, Vijaya Raj; Patel, Sagar S; Michelis, Fotios V; Inamoto, Yoshihiro; Badawy, Sherif M; ... (2022). Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood advances, 6(1), pp. 339-357. American Society of Hematology 10.1182/bloodadvances.2021004916
Nazha, Aziz; Hu, Zhen-Huan; Wang, Tao; Lindsley, R Coleman; Abdel-Azim, Hisham; Aljurf, Mahmoud; Bacher, Ulrike; Bashey, Asad; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; DeFilipp, Zachariah; Diaz, Miguel Angel; Farhadfar, Nosha; Gadalla, Shahinaz M; Gale, Robert Peter; George, Biju; Gergis, Usama; Grunwald, Michael R; Hamilton, Betty; ... (2020). A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes. Biology of blood and marrow transplantation, 26(11), pp. 2139-2146. Elsevier 10.1016/j.bbmt.2020.08.003
Gupta, Vikas; Kim, Soyoung; Hu, Zhen-Huan; Liu, Ying; Aljurf, Mahmoud; Bacher, Vera; Beitinjaneh, Amer; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; Gadalla, Shahinaz M; Gale, Robert Peter; Ganguly, Siddhartha; George, Biju; Gerds, Aaron T; Gergis, Usama; Hamilton, Betty K; Hashmi, Shahrukh; Hildebrandt, Gerhard C; Kamble, Rammurti T; ... (2020). Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS. Blood advances, 4(19), pp. 4748-4757. American Society of Hematology 10.1182/bloodadvances.2020002621
Zhou, Zheng; Nath, Rajneesh; Cerny, Jan; Wang, Hai-Lin; Zhang, Mei-Jie; Abdel-Azim, Hisham; Agrawal, Vaibhav; Ahmed, Gulrayz; Al-Homsi, A Samer; Aljurf, Mahmoud; Alkhateeb, Hassan B; Assal, Amer; Bacher, Vera; Bajel, Ashish; Bashir, Qaiser; Battiwalla, Minocher; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; ... (2020). Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood advances, 4(13), pp. 3180-3190. American Society of Hematology 10.1182/bloodadvances.2019001266
Schmidt, Sarah; Liu, Ying; Hu, Zhen-Huan; Williams, Kirsten M; Lazarus, Hillard M; Vij, Ravi; Kharfan-Dabaja, Mohamed A; Ortí, Guillermo; Wiernik, Peter H; Weisdorf, Daniel; Kamble, Rammurti T; Herzig, Roger; Wirk, Baldeep; Cerny, Jan; Bacher, Ulrike; Chaudhri, Naeem A; Nathan, Sunita; Farhadfar, Nosha; Aljurf, Mahmoud; Gergis, Usama; ... (2020). The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biology of blood and marrow transplantation, 26(6), pp. 1137-1143. Elsevier 10.1016/j.bbmt.2020.02.006
Kim, Haesook T; Ahn, Kwang Woo; Hu, Zhen-Huan; Davids, Matthew S; Volpe, Virginia O; Antin, Joseph H; Sorror, Mohamed L; Shadman, Mazyar; Press, Oliver; Pidala, Joseph; Hogan, William; Negrin, Robert; Devine, Steven; Uberti, Joseph; Agura, Edward; Nash, Richard; Mehta, Jayesh; McGuirk, Joseph; Forman, Stephen; Langston, Amelia; ... (2019). Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report. Clinical cancer research, 25(16), pp. 5143-5155. American Association for Cancer Research 10.1158/1078-0432.CCR-18-3988
